Consultation outcome

Supplementary protection certificate waiver: no deal legislation

• From: Intellectual Property Office
• Published: 5 July 2019
• Last updated: 13 July 2020 — See all updates

This consultation has concluded

Detail of outcome

The government’s response to this consultation is now available.

This response sets out the government’s intended changes to the supplementary protection certificate (SPC) waiver legislation.

These changes will ensure that the legislation continues to work as UK law after the end of the transition period.

---

Original consultation

Summary

We’re seeking views on proposals to fix issues in supplementary protection certificate (SPC) law in the event of a ‘no deal’ EU exit.

This consultation ran from
9am on 5 July 2019 to 11:45pm on 9 August 2019

Consultation description

The EU has recently made changes to legislation on supplementary protection certificates (SPCs), to introduce an “SPC manufacturing waiver”. The waiver allows third party manufacturers to make SPC-protected medicines in certain circumstances.

If the UK leaves the EU without a deal, these changes will automatically become UK law on exit day. Parts of the retained changes will need fixing so that they continue to work as UK law.

The government is seeking views on how we propose to make those fixes. The document explains what the fixes are, and what the proposed legislation looks like.

Documents

Draft legislation: Supplementary Protection Certificate manufacturing waiver in a 'no deal' outcome

PDF, 779 KB, 24 pages

Published 5 July 2019
Last updated 13 July 2020 + show all updates

1. 13 July 2020

   Removal of 'Analysing feedback' note and replacement. Added 'Outcome for consultation' with link.

2. 5 July 2019

   First published.